• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性腹膜后纤维化伴 68Ga-成纤维细胞激活蛋白抑制剂和 18F-FDG 摄取增加。

Idiopathic Retroperitoneal Fibrosis With Intense Uptake of 68Ga-Fibroblast Activation Protein Inhibitor and 18F-FDG.

机构信息

Department of Rheumatology, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing, People's Republic of China.

出版信息

Clin Nucl Med. 2021 Feb 1;46(2):175-176. doi: 10.1097/RLU.0000000000003402.

DOI:10.1097/RLU.0000000000003402
PMID:33208623
Abstract

A 26-year-old man presented with a retroperitoneal mass with left urinary tract obstruction and hydronephrosis recently. 18F-FDG PET/CT showed the retroperitoneal mass had intense and homogeneous FDG avidity. In 68Ga-FAPI PET/CT, the retroperitoneal mass showed intense radioactivity without other organ involvements. The patient was finally diagnosed with idiopathic retroperitoneal fibrosis. After treatment, the follow-up CT showed significant decrease in size of the retroperitoneal mass. The current case indicated that idiopathic retroperitoneal fibrosis had active uptake of 68Ga-FAPI.

摘要

一位 26 岁男性因腹膜后肿块伴左侧尿路梗阻和肾积水就诊。18F-FDG PET/CT 显示腹膜后肿块 FDG 摄取强烈且均匀。68Ga-FAPI PET/CT 显示腹膜后肿块放射性摄取强烈,无其他器官累及。患者最终诊断为特发性腹膜后纤维化。治疗后,随访 CT 显示腹膜后肿块明显缩小。本病例表明特发性腹膜后纤维化对 68Ga-FAPI 有活跃摄取。

相似文献

1
Idiopathic Retroperitoneal Fibrosis With Intense Uptake of 68Ga-Fibroblast Activation Protein Inhibitor and 18F-FDG.特发性腹膜后纤维化伴 68Ga-成纤维细胞激活蛋白抑制剂和 18F-FDG 摄取增加。
Clin Nucl Med. 2021 Feb 1;46(2):175-176. doi: 10.1097/RLU.0000000000003402.
2
Increased 68Ga-FAPI-04 Uptake in Schmorl Node in a Patient With Gastric Cancer.胃癌患者 Schmorl 结节处 68Ga-FAPI-04 摄取增加。
Clin Nucl Med. 2021 Aug 1;46(8):700-702. doi: 10.1097/RLU.0000000000003623.
3
18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT Findings of Abdominal Leiomyosarcoma.18F-FDG PET/CT 和 68Ga-FAPI-04 PET/CT 对腹部平滑肌肉瘤的影像学表现。
Clin Nucl Med. 2021 Dec 1;46(12):e594-e597. doi: 10.1097/RLU.0000000000003673.
4
Intense 68 Ga-Pentixafor Activity in Idiopathic Retroperitoneal Fibrosis.特发性腹膜后纤维化中 68Ga- Pentixafor 的强烈摄取。
Clin Nucl Med. 2022 Dec 1;47(12):e760-e761. doi: 10.1097/RLU.0000000000004375. Epub 2022 Aug 26.
5
Hypermetabolic activity in patients with active retroperitoneal fibrosis on F-18 FDG PET: report of three cases.F-18 FDG PET检查显示活动性腹膜后纤维化患者的高代谢活性:三例报告
Ann Nucl Med. 2008 Jan;22(1):87-92. doi: 10.1007/s12149-007-0077-0.
6
Persistent FDG/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapse.特发性腹膜后纤维化患者 FDG/PET CT 摄取持续存在有助于识别复发风险较高的患者。
Eur J Intern Med. 2019 Apr;62:67-71. doi: 10.1016/j.ejim.2019.01.019. Epub 2019 Jan 31.
7
Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT: Comparison With 18F-FDG PET/CT in 22 Different Cancer Types.68Ga-DOTA-FAPI-04 PET/CT 肿瘤成像:与 18F-FDG PET/CT 在 22 种不同癌症类型中的比较。
Clin Nucl Med. 2022 Apr 1;47(4):e333-e339. doi: 10.1097/RLU.0000000000004073.
8
Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Imaging of Pancreatic Cancer With Liver Metastases.68Ga-FAPI 与 18F-FDG PET/CT 对胰腺癌细胞肝转移的影像学比较。
Clin Nucl Med. 2021 Jul 1;46(7):589-591. doi: 10.1097/RLU.0000000000003561.
9
Comparison of 68Ga-FAPI and 18F-FDG PET/CT in Dermatofibrosarcoma Protuberans.68Ga-FAPI 与 18F-FDG PET/CT 在隆突性皮肤纤维肉瘤中的比较。
Clin Nucl Med. 2022 Jul 1;47(7):629-631. doi: 10.1097/RLU.0000000000004212. Epub 2022 Apr 22.
10
68Ga-FAPI PET/CT Detected Non-FDG-Avid Gastric Stromal Tumor.68Ga-FAPI PET/CT 检测到非 FDG 摄取的胃间质瘤。
Clin Nucl Med. 2022 Mar 1;47(3):226-227. doi: 10.1097/RLU.0000000000003856.

引用本文的文献

1
SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET.SNMMI成纤维细胞活化蛋白(FAP)PET程序标准/EANM实践指南
J Nucl Med. 2025 Jan 3;66(1):26-33. doi: 10.2967/jnumed.124.269002.
2
Nuclear medicine imaging in non-seminomatous germ cell tumors: lessons learned from the past failures.核医学成像在非精原细胞瘤生殖细胞肿瘤中的应用:从过去的失败中吸取的教训。
Cancer Imaging. 2024 Nov 18;24(1):156. doi: 10.1186/s40644-024-00794-5.
3
Uraemia with imbalanced calcium phosphorus metabolism on [Ga]Ga-FAPI versus [F]F-FDG PET/CT.
[镓]Ga-FAPI与[氟]F-FDG PET/CT在钙磷代谢失衡的尿毒症中的应用
Eur J Nucl Med Mol Imaging. 2024 Jun;51(7):2156-2158. doi: 10.1007/s00259-024-06655-4. Epub 2024 Feb 19.
4
Potential applications of PET/MRI in non-oncologic conditions within the abdomen and pelvis.正电子发射断层扫描/磁共振成像在腹部和骨盆非肿瘤性疾病中的潜在应用。
Abdom Radiol (NY). 2023 Dec;48(12):3624-3633. doi: 10.1007/s00261-023-03922-0. Epub 2023 May 5.
5
FAP expression in alpha cells of Langherhans insulae-implications for FAPI radiopharmaceuticals' use.胰岛α细胞中 FAP 的表达——对 FAPI 放射性药物应用的启示。
Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):3042-3049. doi: 10.1007/s00259-023-06246-9. Epub 2023 May 4.
6
Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?成纤维细胞激活蛋白(FAP)特异性放射性配体可否被视为泛肿瘤药物?
Contrast Media Mol Imaging. 2022 Feb 22;2022:3948873. doi: 10.1155/2022/3948873. eCollection 2022.
7
Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond.基于成纤维细胞激活蛋白抑制剂的放射性药物的临床总结:癌症及其他。
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2844-2868. doi: 10.1007/s00259-022-05706-y. Epub 2022 Jan 31.
8
Increased uptake of Ga-DOTA-FAPI-04 in bones and joints: metastases and beyond.Ga-DOTA-FAPI-04 在骨骼和关节中的摄取增加:转移灶及其他。
Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):709-720. doi: 10.1007/s00259-021-05472-3. Epub 2021 Jul 9.
9
State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis.FAPI-PET 成像的最新技术:系统评价和荟萃分析。
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4396-4414. doi: 10.1007/s00259-021-05475-0. Epub 2021 Jun 25.